Scholars@Duke

Abstract 5 Human Umbilical Cord Blood-Derived Cell Therapy Product, DUOC-01, Promotes Remyelination by Driving the Differentiation of Oligodendrocyte Progenitor Cells

Publication ,  Conference
Xu, L; Saha, A; Parrott, R; O’Neil, S; Kurtzberg, J; Filiano, A
Published in: Stem Cells Translational Medicine
September 6, 2022
Published version (DOI) Publisher Link

Duke Scholars

Joanne Kurtzberg
Author Joanne Kurtzberg Pediatrics, Transplant and Cellular Therapy

Published In

Stem Cells Translational Medicine

DOI

10.1093/stcltm/szac057.005

EISSN

2157-6580

ISSN

2157-6564

Publication Date

September 6, 2022

Volume

11

Issue

Supplement_1

Start / End Page

S7 / S7

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • 4003 Biomedical engineering
  • 3206 Medical biotechnology
  • 1103 Clinical Sciences
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Xu, L., Saha, A., Parrott, R., O’Neil, S., Kurtzberg, J., & Filiano, A. (2022). Abstract 5 Human Umbilical Cord Blood-Derived Cell Therapy Product, DUOC-01, Promotes Remyelination by Driving the Differentiation of Oligodendrocyte Progenitor Cells. In Stem Cells Translational Medicine (Vol. 11, pp. S7–S7). Oxford University Press (OUP). https://doi.org/10.1093/stcltm/szac057.005
Xu, Li, Arjun Saha, Roberta Parrott, Shane O’Neil, Joanne Kurtzberg, and Anthony Filiano. “Abstract 5 Human Umbilical Cord Blood-Derived Cell Therapy Product, DUOC-01, Promotes Remyelination by Driving the Differentiation of Oligodendrocyte Progenitor Cells.” In Stem Cells Translational Medicine, 11:S7–S7. Oxford University Press (OUP), 2022. https://doi.org/10.1093/stcltm/szac057.005.
Xu L, Saha A, Parrott R, O’Neil S, Kurtzberg J, Filiano A. Abstract 5 Human Umbilical Cord Blood-Derived Cell Therapy Product, DUOC-01, Promotes Remyelination by Driving the Differentiation of Oligodendrocyte Progenitor Cells. In: Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S7–S7.
Xu, Li, et al. “Abstract 5 Human Umbilical Cord Blood-Derived Cell Therapy Product, DUOC-01, Promotes Remyelination by Driving the Differentiation of Oligodendrocyte Progenitor Cells.” Stem Cells Translational Medicine, vol. 11, no. Supplement_1, Oxford University Press (OUP), 2022, pp. S7–S7. Crossref, doi:10.1093/stcltm/szac057.005.
Xu L, Saha A, Parrott R, O’Neil S, Kurtzberg J, Filiano A. Abstract 5 Human Umbilical Cord Blood-Derived Cell Therapy Product, DUOC-01, Promotes Remyelination by Driving the Differentiation of Oligodendrocyte Progenitor Cells. Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S7–S7.

Published In

Stem Cells Translational Medicine

DOI

10.1093/stcltm/szac057.005

EISSN

2157-6580

ISSN

2157-6564

Publication Date

September 6, 2022

Volume

11

Issue

Supplement_1

Start / End Page

S7 / S7

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • 4003 Biomedical engineering
  • 3206 Medical biotechnology
  • 1103 Clinical Sciences
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology